• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
China Influenza Vaccine Industry Report 2014 Product Image

China Influenza Vaccine Industry Report 2014

  • ID: 2729042
  • January 2014
  • Region: China
  • 201 Pages
  • QYresearch

FEATURED COMPANIES

  • Abbott (US)
  • CCBIO (Jilin Changchun)
  • Crucell (Holland)
  • GSK (UK)
  • Hualan Bio (Henan)
  • Novartis (Switzerland)
  • MORE

The China Influenza Vaccine Industry Report 2014 is a professional and in-depth study on the current state of the influenza vaccine industry in China.

The report provides a basic overview of the industry including definitions, classifications, inoculation, industry chain structure and development prospects. Influenza vaccine manufacturing technology and processes are discussed looking at equipment, process problems and technology. Production, demand, cost, price, production value and gross margin statistics are also provided.

A key feature of the report is its focus on 16 industry players providing information such as capacity production, cost, price, production value, profit margins and other relevant data. Next the feasibility of a new 8 Million Pieces/year influenza vaccine investment project is assessed. Finally the report offers overall research conclusions offered.

With 154 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

FEATURED COMPANIES

  • Abbott (US)
  • CCBIO (Jilin Changchun)
  • Crucell (Holland)
  • GSK (UK)
  • Hualan Bio (Henan)
  • Novartis (Switzerland)
  • MORE

Chapter One Influenza Vaccine Industry Overview
1.1 Definition
1.2 Classification
1.2.1 Seasonal Influenza Vaccine
1.2.2 Type A H1N1 Influenza Vaccine
1.2.3 Two Type Influenza Vaccine Comparison
1.3 Vaccine Inoculation
1.4 Industry Chain Structure
1.5 Influenza Vaccine Development Prospect
1.5.1 United States Overplus
1.5.2 Seek Competitive Differentiation New Technology Prevalence
1.5.3 Huge Market Demand in China

Chapter Two Influenza Vaccine Manufacturing Technology and Process
2.1 Influenza Vaccine Manufacturing Technology Overview
2.1.1 Embryo Culture Type A H1N1 Influenza Vaccine Manufacturing Process
2.1.2 Vero Cell Culture Inactivated Influenza Vaccine Manufacturing Process
2.2 Comparison of Two Procee Method
2.2.1 Embryo Culture Inactivated Influenza Vaccine Process Flow
2.2.2 Cell Culture Inactivated Influenza Vaccine Process Flow
2.2.3 Two Manufacturing Process Comparison
2.3 Influenza Vaccine Manufacturing Equipments List
2.4 Influenza Vaccine Manufacturing Process Today and Tomorrow
2.4.1 Influenza Vaccine Manufacturing Process Status
2.4.2 H1N1 Influenza Vaccine Manufacturing Process Problems
2.4.3 Influenza Vaccine New Manufacturing Technology

Chapter Three Influenza Vaccine Production Supply Sales Demand Market Status and Forecast
3.1 Influenza Vaccine Productions Overview
3.2 Influenza Vaccine Demand Overview
3.4 Influenza Vaccine Cost Price Production Value Gross Margin

Chapter Four Influenza Vaccine Key Manufacturers
4.1 Hualan Bio (Henan)
4.2 Sinovac (Beijing)
4.3 Tianyuan Bio-pharma (Zhejiang)
4.4 Changsheng (Jilin Changchun)
4.5 Aleph Biomedical (Liaoning)
4.6 SIOBP (Shanghai)
4.7 CCBIO (Jilin Changchun)
4.8 Lanzhou Institute of Biological Products (Qinghai)
4.9 Tiantan Biological (Beijing)
4.10 Sanofi-pasteur (France)
4.11 GSK (UK)
4.12 Novartis (Switzerland)
4.13 Abbott (US)
4.14 Crucell (Holland)
4.15 Tasly&Jenner (Tianjin)
4.16 Neptunus Interlong (Shenzhen)

Chapter Five China 8Million Pieces/Year Influenza Vaccine Project Investment Feasibility Analysis
5.1 China 8Million Pieces/Year Influenza Vaccine Project Opportunities and Risks Analysis
5.1.1 Opportunities
5.1.2 Risks
5.3 China 8Million Pieces/Year Influenza Vaccine Project Investment Feasibility Analysis
5.3.1 Project Overview
5.3.2 Capacity
5.3.3 Construction Standards
5.3.3 Construction Period
5.3.4 Project Schedule
5.3.5 Investment Feasibility Analysis

Chapter Six Influenza Vaccine Industry Research Conclusions

Tables and Figures

Table Common Vaccines Classification
Table United States Approval Type A influenza H1N1 Vaccine Suppliers and Product Specifications List
Table Europe Approval Type A influenza H1N1 Vaccine Suppliers and Product Specifications List
Table China First Type Vaccine and Second Type Vaccine Classification and Application
Table First Type Vaccine and Second Type Vaccine Detail Market Analysis
Table 2009-2013 China First Type Vaccine and Second Type Vaccine Issue Number (10K Pieces) and Market Share
Figure 2013 State-owned Private Foreign Enterprise Market Share in First Type Vaccine and Second Type Vaccine
Figure Influenza Vaccine Industry Chain Structure
Figure Vaccine Cold Chain Circulation System
Figure Vaccine Transportation Model
Figure First Type Vaccine Transportation Channel
Figure Second Type Vaccine Transportation Channel
Figure Vaccine Transportation Steps and Process
Figure 2009-2019 Global Influenza Vaccine Market Scale(100 Million USD)
Figure 2013 United States TOP5 Suppliers Influenza Vaccine Market Share
Figure China Influenza Vaccine Inoculation Coverage Rate and Its Gap to International Goal
Table Baxter Vero Cell Platform Background Information
Figure Embryo Culture Inactivated Vaccine Manufacturing Process Flow
Figure Cell Culture Inactivated Influenza Vaccine Manufacturing Process Flow
Figure Two Influenza Vaccine Manufacturing Process Comparison
Figure Influenza Vaccine Manufacturing Steps
Figure Influenza Vaccine Detection Steps
Table Influenza Vaccine Manufacturing Equipments List (38 Equipments)
Figure Influenza Vaccine Production Periodic Table
Figure Influenza Vaccine Production schedules
Table Influenza Vaccine Development History
Table Existing and R&D Influenza Vaccine Products List
Figure Influenza Vaccine New Manufacturing Technology
Table China 11 Manufacturers Influenza Vaccine Market Status List
Table Selling Influenza Vaccine in China 5 Foreign Suppliers List
Table 2009-2017 China 11 Manufacturers Influenza Vaccine Capacity and Total Capacity (10K Pieces) List
Table 2009-2017 China 11 Manufacturers Influenza Vaccine Capacity Market Share List
Table 2009-2017 China 11 Manufacturers Influenza Vaccine Production and Total Production (10K Pieces) List
Table 2009-2017 China 11 Manufacturers Influenza Vaccine Production Market Share List
Table 2009-2017 China Influenza Vaccine Capacity Production (10K Pieces) and Capacity Utilization Rate
Figure 2009-2017 China Influenza Vaccine Capacity Production (10K Pieces) and Growth Rate
Figure 2013 China Key Manufacturers Influenza Vaccine Production Market Share (China Government Approcal Data)
Table 2009-2017 Global Key Suppliers Influenza Vaccine Capacity and Total Capacity (100 Million Pieces) List
Table 2009-2017 Global Key Suppliers Influenza Vaccine Production and Total Production (100 Million Pieces) List
Figure 2009-2017 Global Influenza Vaccine Capacity Production (100 Million Pieces) and Growth Rate
Table 2009-2017 Global Influenza Vaccine Capacity Production (100 Million Pieces) and Capacity Utilization Rate
Figure 2011 Global Key Suppliers Influenza Vaccine Production Market Share
Table 2009-2017 Global Key Suppliers Influenza Vaccine China Sales (10K Pieces) List
Figure 2013 China Imported Influenza Vaccine Market Share By Suppliers (China Government Approval Data)
Table Global and China Key Suppliers Key Vaccine Products Sales in China
Table 2007-2011 China Influenza Vaccine Approval Amount by Suppliers (10K Pieces)
Figure 2013 China Influenza Vaccine Market Share by Splitting Vaccine and Subunit Vaccine (according China government approval amount)
Table 2009-2017 China local Influenza Vaccine and Imported Influenza Vaccine Market Share Comparison
Table 2001-2020 China Birth Rate and Population (10K)
Figure China India Korea Japan etc 9 Countries Child Mortality (‰)
Figure 1950-2050 China Working-age Population Proportion (%)
Table 2000-2050 China Age Over 60 Population (100 Million) and Proportion (%)
Figure 2010-2050 China Age Over 60 Over 65 Over 80 Population Proportion
Table 2001-2015 China Per Capita GDP (USD) and Growth Rate
Figure 2009-2017 China Influenza Vaccine Supply Demand (10K Pieces) and Growth Rate
Figure China Japan France etc 9 Countries Age Over 65 Population Influenza Vaccine Inoculation Coverage Rate
Table 2009-2017 China Influenza Vaccine Supply Demand and Shortage (10K Pieces)
Table 2013 Hangzhou Disease Control and Prevention Center 33 Type Influenza Vaccine Products Purchase and Selling Price (RMB/Piece)
Table 2013 China and Imported Influenza Vaccine Capacity Production (10K Pieces) Price Cost Profit (RMB/Piece) Gross Margin List
Table 2009-2017 China Influenza Vaccine Capacity Production (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List
Table Hualan Bio Company Information Table(Products Development History Location Background Contact Information etc 14 Items)
Figure Hualan Bio Vaccine Factory Picture
Figure Hualan Bio Influenza Virus Split Vaccine (Childhood Type)
Figure Hualan Bio Influenza Virus Split Vaccine (Adult Type)
Figure Hualan Bio Type A H1N1 Influenza Virus Split Vaccine
Table 2009-2017 Hualan Bio Influenza Virus Split Vaccine Capacity Production (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List
Figure 2009-2017 Hualan Bio Influenza Virus Split Vaccine Capacity Production (10K Pieces) and Growth Rate
Table Sinovac Biotech Company Information Table(Products Development History Location Background Contact Information etc 14 Items)
Table Sinovac Biotech Vaccine Plant Picture
Table Sinovac Biotech Development History Time Table
Figure Sinovac Biotech Influenza Virus Split Vaccine-Anrlaifu
Figure Sinovac Biotech Pandemic Influenza Virus Inactivated Vaccine - Panrlaifu
Figure Sinovac Biotech Type A H1N1 Influenza Virus Split Vaccine - Panrlaifu.1
Table 2009-2017 Sinovac Biotech Influenza Virus Split Vaccine Capacity Production (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List
Figure 2009-2017 Sinovac Biotech Influenza Virus Split Vaccine Capacity Production (10K Pieces) and Growth Rate
Table Tianyuan Bio-pharma Company Information Table(Products Development History Location Background Contact Information etc 14 Items)
Figure Tianyuan Bio-pharma Influenza Vaccine Products List
Figure Tianyuan Bio-pharma Influenza Virus Split Vaccine - Yuganning
Table 2009-2017 Tianyuan Bio-pharma Influenza Virus Split Vaccine Capacity Production (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List
Figure 2009-2017 Tianyuan Bio-pharma Influenza Virus Split Vaccine Capacity Production (10K Pieces) and Growth Rate
Table Changsheng Company Information Table(Products Development History Location Background Contact Information etc 14 Items)
Figure Changsheng Influenza Virus Split Vaccine - Wanxin
Figure Changsheng Type A H1N1 Influenza Virus Split Vaccine
Table 2009-2017 Changsheng Influenza Virus Split Vaccine Capacity Production (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List
Figure 2009-2017 Changsheng Influenza Virus Split Vaccine Capacity Production (10K Pieces) and Growth Rate
Table Aleph Biomedical Company Information Table(Products Development History Location Background Contact Information etc 14 Items)
Table Aleph Biomedical Contact Information List
Figure Aleph Biomedical Influenza Vaccine Manufacturing Workshop
Figure Aleph Biomedical Influenza Virus Split Vaccine(Adult Type)
Figure Aleph Biomedical Influenza Virus Split Vaccine (Childhood Type)
Table 2009-2017 Aleph Biomedical Influenza Virus Split Vaccine Capacity Production (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List
Figure 2009-2017 Aleph Biomedical Influenza Virus Split Vaccine Capacity Production (10K Pieces) and Growth Rate
Table SIOBP (Shanghai Institute of Biological Products) Company Information Table(Products Development History Location Background Contact Information etc 14 Items)
Figure CNBG and Six Institutes Equity Relationship
Figure SIOBP Influenza Virus Split Vaccine
Figure SIOBP Type A H1N1 Influenza Virus Split Vaccine
Table 2009-2017 SIOBP Influenza Virus Split Vaccine Capacity Production (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List
Figure 2009-2017 SIOBP Influenza Virus Split Vaccine Capacity Production (10K Pieces) and Growth Rate
Table CCBIO(Changchun Institute of Biological Products) Company Information Table(Products Development History Location Background Contact Information etc 14 Items)
Figure CCBIO Influenza Split Vaccine - Shipulir
Figure CCBIO Factory Workshop Picture
Table 2009-2017 CCBIO Influenza Virus Split Vaccine Capacity Production (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List
Figure 2009-2017 CCBIO Influenza Virus Split Vaccine Capacity Production (10K Pieces) and Growth Rate
Table Lanzhou Institute of Biological Products Company Information Table(Products Development History Location Background Contact Information etc 14 Items)
Figure Lanzhou Institute of Biological Products Factory Picture
Table Lanzhou Institute of Biological Products Trivalent Influenza Split Vaccine
Table 2009-2017 Lanzhou Institute of Biological Products Influenza Virus Split Vaccine Capacity Production (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List
Figure 2009-2017 Lanzhou Institute of Biological Products Influenza Virus Split Vaccine Capacity Production (10K Pieces) and Growth Rate
Table Tiantan Biological Company Information Table(Products Development History Location Background Contact Information etc 14 Items)
Figure Tiantan Biological Control Shares of Sinopharm
Figure Tiantan Biological and Related Control Subsidiaries Relationship
Figure Tiantan Biological Factory Picture
Figure Tiantan Biological Beijing Yizhuang Vaccine Plants Picture
Figure Tiantan Biological Type A H1N1 Influenza Virus Split Vaccine
Figure Tiantan Biological Influenza Virus Split Vaccine
Table 2009-2017 Tiantan Biological Influenza Virus Split Vaccine Capacity Production (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List
Figure 2009-2017 Tiantan Biological Influenza Virus Split Vaccine Capacity Production (10K Pieces) and Growth Rate
Table Sanofi-pasteur Company Information Table(Products Development History Location Background Contact Information etc 14 Items)
Figure Sanofi-pasteur China Pharmaceutical Factories Distribution
Figure Influenza Virus Split Vaccine-Fanrling
Table 2009-2017 Sanofi-pasteur Influenza Virus Split Vaccine Capacity Production (100Million Pieces) China Sales (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List
Figure 2009-2017 Sanofi-pasteur Influenza Virus Split Vaccine Capacity Production (100Million Pieces) and Growth Rate
Table GSK Company Information Table(Products Development History Location Background Contact Information etc 14 Items)
Figure GSK Shenzhen Influenza Vaccine Workshop Pictures
Figure GSK Influenza Split Vaccine - Fluarix
Table 2009-2017 GSKInfluenza Virus Split Vaccine Capacity Production (100Million Pieces) China Sales (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List
Figure 2009-2017 GSKInfluenza Virus Split Vaccine Capacity Production (100Million Pieces) and Growth Rate
Table Novartis Company Information Table(Products Development History Location Background Contact Information etc 14 Items)
Figure Novartis Subunit Influenza Vaccine - Agrippal
Figure Novartis Aged Population Special Use Influenza Vaccine - Fluad
Table 2009-2017 Novartis Influenza Virus Subunit Vaccine Capacity Production (100Million Pieces) China Sales (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List
Figure 2009-2017 Novartis Influenza Virus Subunit Vaccine Capacity Production (100Million Pieces) and Growth Rate
Table Abbott Company Information Table(Products Development History Location Background Contact Information etc 14 Items)
Figure Abbott Influenza Subunit Vaccine - Influvac
Table 2009-2017 Abbott Subunit Influenza Vaccine Capacity Production (100Million Pieces) China Sales (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List
Figure 2009-2017 Abbott Subunit Influenza Vaccine Capacity Production (100Million Pieces) and Growth Rate
Table Crucell Company Information Table(Products Development History Location Background Contact Information etc 14 Items)
Table Crucell Selling Vaccines and R&D Projects List
Table Crucell V Type Virion Adjuvant Influenza Vaccine (Subunit ) - Inflexal
Table 2009-2017 Crucell Subunit Influenza Vaccine Capacity Production (100Million Pieces) China Sales (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List
Table 2009-2017 Crucell Subunit Influenza Vaccine Capacity Production (100Million Pieces) and Growth Rate
Table Tasly&Jenner Company Information Table(Products Development History Location Background Contact Information etc 14 Items)
Figure Tasly&Jenner Factory Pictures
Figure Tasly&Jenner Subunit Influenza Virus Split Vaccine-Fuluoke®
Table 2009-2017 Tasly&Jenner Influenza Virus Subunit Vaccine Capacity Production (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List
Table 2009-2017 Tasly&Jenner Influenza Virus Subunit Vaccine Capacity Production (10K Pieces) and Growth Rate
Table Neptunus Interlong Company Information Table(Products Development History Location Background Contact Information etc 14 Items)
Figure Neptunus Interlong Vaccine Factory Picture
Figure Neptunus Interlong Vaccine Workshop Picture
Figure Neptunus Interlong Influenza Subunit Vaccine Package
Table 2009-2017 Neptunus Interlong Influenza Virus Subunit Vaccine Capacity Production (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List
Table 2009-2017 Neptunus Interlong Influenza Virus Subunit Vaccine Capacity Production (10K Pieces) and Growth Rate
Table China 8Million Pieces/Year Influenza Vaccine Project Investments List
Table China 8Million Pieces/Year Influenza Vaccine Project Investment Feasibility Analysis

- Abbott (US)
- Aleph Biomedical (Liaoning)
- CCBIO (Jilin Changchun)
- Changsheng (Jilin Changchun)
- Crucell (Holland)
- GSK (UK)
- Hualan Bio (Henan)
- Lanzhou Institute of Biological Products (Qinghai)
- Neptunus Interlong (Shenzhen)
- Novartis (Switzerland)
- SIOBP (Shanghai)
- Sanofi-pasteur (France)
- Sinovac (Beijing)
- Tasly&Jenner (Tianjin)
- Tiantan Biological (Beijing)
- Tianyuan Bio-pharma (Zhejiang)

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos